8.42 USD
+0.08
0.96%
At close Apr 30, 4:00 PM EDT
After hours
8.29
-0.13
1.54%
1 day
0.96%
5 days
6.99%
1 month
-3.33%
3 months
-26.27%
6 months
-29.18%
Year to date
-32.21%
1 year
-27.23%
5 years
-49.79%
10 years
-88.35%
 

About: Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Employees: 32,000

0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

43% more first-time investments, than exits

New positions opened: 139 | Existing positions closed: 97

17% more funds holding in top 10

Funds holding in top 10: 12 [Q3] → 14 (+2) [Q4]

13% more capital invested

Capital invested by funds: $10.9B [Q3] → $12.4B (+$1.47B) [Q4]

4.55% more ownership

Funds ownership: 78.82% [Q3] → 83.37% (+4.55%) [Q4]

2% more funds holding

Funds holding: 984 [Q3] → 1,008 (+24) [Q4]

0% more call options, than puts

Call options by funds: $35M | Put options by funds: $34.9M

18% less repeat investments, than reductions

Existing positions increased: 306 | Existing positions reduced: 374

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$9
7%
upside
Avg. target
$10.50
25%
upside
High target
$13
54%
upside

4 analyst ratings

positive
25%
neutral
25%
negative
50%
Jefferies
Glen Santangelo
45% 1-year accuracy
5 / 11 met price target
54%upside
$13
Buy
Maintained
7 Mar 2025
Piper Sandler
David Amsellem
56% 1-year accuracy
18 / 32 met price target
19%upside
$10
Neutral
Reiterated
5 Mar 2025
Barclays
Balaji Prasad
21% 1-year accuracy
9 / 43 met price target
7%upside
$9
Underweight
Maintained
28 Feb 2025
B of A Securities
Jason Gerberry
26% 1-year accuracy
5 / 19 met price target
19%upside
$10
Underperform
Maintained
28 Feb 2025

Financial journalist opinion

Based on 369 articles about VTRS published over the past 30 days

Neutral
Accesswire
1 hour ago
Viatris Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
NEW YORK, NY / ACCESS Newswire / April 30, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=146308&wire=1 or contact Joseph E. Levi, Esq.
Viatris Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
Neutral
Accesswire
5 hours ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. Lawsuit – VTRS
NEW YORK, NY / ACCESS Newswire / April 30, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=146265&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. Lawsuit – VTRS
Neutral
Accesswire
5 hours ago
VTRS ANNOUNCEMENT: Viatris Inc. Investors May Have Been Affected by Fraud - Contact BFA Law Before June 3 Court Deadline
NEW YORK CITY, NY / ACCESS Newswire / April 30, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ:VTRS) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Viatris, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/viatris-inc.
VTRS ANNOUNCEMENT: Viatris Inc. Investors May Have Been Affected by Fraud - Contact BFA Law Before June 3 Court Deadline
Neutral
PRNewsWire
9 hours ago
Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BENSALEM, Pa. , April 30, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Neutral
Accesswire
10 hours ago
Shareholders That Lost Money on Viatris Inc. (VTRS) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESS Newswire / April 30, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=146235&wire=1 or contact Joseph E. Levi, Esq.
Shareholders That Lost Money on Viatris Inc. (VTRS) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Neutral
Accesswire
10 hours ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
NEW YORK CITY, NY / ACCESS Newswire / April 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Viatris, Inc. ("Viatris" or the "Company") (NASDAQ:VTRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
Neutral
Accesswire
13 hours ago
Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - VTRS
NEW YORK, NY / ACCESS Newswire / April 30, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=146151&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - VTRS
Neutral
Accesswire
13 hours ago
Class Action Filed Against Viatris Inc. (VTRS) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / April 30, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=146125&wire=1 or contact Joseph E. Levi, Esq.
Class Action Filed Against Viatris Inc. (VTRS) Seeking Recovery for Investors - Contact Levi & Korsinsky
Neutral
Accesswire
14 hours ago
SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Viatris Inc. (NASDAQ:VTRS)
NEW YORK, NY / ACCESS Newswire / April 30, 2025 / Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a complaint has been filed in the United States District Court for the Western District of Pennsylvania on behalf of investors who purchased or acquired the securities of Viatris, Inc. ("Viatris" or the "Company") (NASDAQ:VTRS) between August 8, 2024 and February 26, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers (the "Complaint"). If you purchased or acquired Viatris securities, and/or would like to discuss your legal rights and options please visit Viatris Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.
SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Viatris Inc. (NASDAQ:VTRS)
Neutral
Accesswire
14 hours ago
VTRS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Viatris Inc. to Contact the Firm Today!
NEW YORK CITY, NY / ACCESS Newswire / April 30, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Viatris Inc. ("Viatris" or "the Company") (NASDAQ:VTRS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Viatris securities between August 8, 2024 and February 26, 2025, both dates inclusive (the "Class Period").
VTRS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Viatris Inc. to Contact the Firm Today!
Charts implemented using Lightweight Charts™